GGrantIndex
← Leaderboards

Da-Zhi Wang

University Of South Florida

Google Scholar ↗PubMed ↗ORCID ↗
$21,157,099
Attributed
$28,277,259
Total exposure
13
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,277,259 · 13

By mechanism

R01$28,277,259 · 13

Top collaborators

Most similar at University Of South Florida

Same institution · by research overlap

Others in their field

Top investigators on “Molecular”

Research focus

MolecularPlayCardiovascular DiseasesIn VivoPathway InteractionsMediatingOverexpressionHeartCardiacRegulationMicrornasCause Of DeathGeneticCardiogenesisHeart DiseasesGene ExpressionKnockout MiceCardiac MyocytesInsightProteinsHeart HypertrophyMouse ModelHeart FailureResponse

Grant awards (51)

Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$870,663
R01 · FY2025 · HL
Targeting Endothelial Epsins to Ameliorate Myocardial Ischemia$775,931
R01 · FY2025 · HL
CDK13 function in heart development and congenital heart disease$701,842
R01 · FY2025 · HL · contact PI
Function and Mechanism of the Intercalated Disc Protein XinB in Cardiomyocyte Proliferation and Cardiac Regeneration$564,053
R01 · FY2025 · HL · contact PI
lncRNA Function and Mechanisms during Cardiac Development and Disease$560,702
R01 · FY2025 · HL · contact PI
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$853,248
R01 · FY2024 · HL
Targeting Endothelial Epsins to Ameliorate Myocardial Ischemia$833,681
R01 · FY2024 · HL
Function and Mechanism of the Intercalated Disc Protein XinB in Cardiomyocyte Proliferation and Cardiac Regeneration$552,772
R01 · FY2024 · HL · contact PI
lncRNA Function and Mechanisms during Cardiac Development and Disease$549,488
R01 · FY2024 · HL · contact PI
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$870,663
R01 · FY2023 · HL
CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease$838,978
R01 · FY2023 · HL
Function and Mechanism of the Intercalated Disc Protein XinB in Cardiomyocyte Proliferation and Cardiac Regeneration$563,582
R01 · FY2023 · HL · contact PI
lncRNA Function and Mechanisms during Cardiac Development and Disease$559,768
R01 · FY2023 · HL · contact PI
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$928,413
R01 · FY2022 · HL
CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease$838,978
R01 · FY2022 · HL
Molecular Mechanisms of Dystrophic Cardiomyopathy$503,157
R01 · FY2022 · HL · contact PI
Epsin in Angiogenesis and Vascular Remodeling$882,499
R01 · FY2021 · HL
CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease$838,978
R01 · FY2021 · HL
MOLECULAR MECHANISMS OF DYSTROPHIC CARDIOMYOPATHY$518,390
R01 · FY2021 · HL · contact PI
Molecular Mechanisms of Dystrophic Cardiomyopathy$65,308
R01 · FY2021 · HL · contact PI
Epsin in Angiogenesis and Vascular Remodeling$882,499
R01 · FY2020 · HL
CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease$762,210
R01 · FY2020 · HL
MOLECULAR MECHANISMS OF DYSTROPHIC CARDIOMYOPATHY$595,711
R01 · FY2020 · HL · contact PI
MicroRNAs, cardiac function and cardiomyopathy$523,124
R01 · FY2020 · HL · contact PI
MicroRNAs, cardiac function and cardiomyopathy$12,243
R01 · FY2020 · HL · contact PI
Epsin in Angiogenesis and Vascular Remodeling$882,499
R01 · FY2019 · HL
MOLECULAR MECHANISMS OF DYSTROPHIC CARDIOMYOPATHY$595,711
R01 · FY2019 · HL · contact PI
MicroRNAs, cardiac function and cardiomyopathy$535,367
R01 · FY2019 · HL · contact PI
Therapeutic applications of miRNAs in myocardial and cardiac regeneration$442,500
R01 · FY2019 · HL · contact PI
Epsin in Angiogenesis and Vascular Remodeling$883,049
R01 · FY2018 · HL
MicroRNAs, cardiac function and cardiomyopathy$535,367
R01 · FY2018 · HL · contact PI
Therapeutic applications of miRNAs in myocardial and cardiac regeneration$442,500
R01 · FY2018 · HL · contact PI
MicroRNAs, cardiac function and cardiomyopathy$535,367
R01 · FY2017 · HL · contact PI
Therapeutic applications of miRNAs in myocardial and cardiac regeneration$442,500
R01 · FY2017 · HL · contact PI
Therapeutic applications of miRNAs in myocardial and cardiac regeneration$442,500
R01 · FY2016 · HL · contact PI
Molecular Mechanisms of Dilated Cardiomyopathy$442,500
R01 · FY2016 · HL · contact PI
Molecular Mechanisms of Dilated Cardiomyopathy$435,246
R01 · FY2015 · HL · contact PI
MicroRNAs, cardiac development and function$428,475
R01 · FY2015 · HL · contact PI
Molecular mechanisms of dilated cardiomyopathy$430,587
R01 · FY2014 · HL · contact PI
MicroRNAs, cardiac development and function$426,300
R01 · FY2014 · HL · contact PI
Molecular mechanisms of dilated cardiomyopathy$416,500
R01 · FY2013 · HL · contact PI
MicroRNAs, cardiac development and function$414,120
R01 · FY2013 · HL · contact PI
MicroRNAs, cardiac development and function$435,000
R01 · FY2012 · HL · contact PI
MicroRNAs, cardiac development and function$428,959
R01 · FY2010 · HL · contact PI
MicroRNAs, cardiac development and function$363,108
R01 · FY2009 · HL · contact PI
MicroRNAs, cardiac development and function$363,108
R01 · FY2008 · HL · contact PI
MicroRNAs, cardiac development and function$363,108
R01 · FY2007 · HL · contact PI
Transcriptional control of cardiac development$276,869
R01 · FY2007 · HL · contact PI
Transcriptional control of cardiac development$285,138
R01 · FY2006 · HL · contact PI
Transcriptional control of cardiac development$292,000
R01 · FY2005 · HL
Transcriptional control of cardiac development$292,000
R01 · FY2004 · HL